Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan · Delayed Price · Currency is TWD 136.50
+7.50 (5.81%)
At close: May 8, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 7.01 billion as of May 8, 2026. Its market cap has increased by 147.23% in one year.
Market Cap
7.01B
Enterprise Value
6.63B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
136.50
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 7.01B, an increase of 235.64%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 7.01B | 22.42% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 15.61B |
| TCM Biotech International | 9.21B |
| Libo Pharma | 3.01B |
| TEH SENG Pharmaceutical Mfg. | 1.96B |
| Protect Animal Health | 1.95B |
| TSA International | 1.88B |
| Timing Pharmaceutial | 1.73B |
| Gin Hwa Biotech Incorporation | 1.69B |